1997
DOI: 10.1016/s0959-8049(97)00039-7
|View full text |Cite
|
Sign up to set email alerts
|

Long-term, totally implantable central venous access ports connected to a Groshong atheter for chemotherapy of solid tumours: Experience from 178 cases using a single type of device

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
55
1
2

Year Published

2001
2001
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(66 citation statements)
references
References 15 publications
6
55
1
2
Order By: Relevance
“…The most important factors contributing to this complication are the experience of the surgeon and the attention paid to the anatomical landmarks. 10 In our series, only one case (0.42%) developed pneumothorax, which was treated by tube drainage. In four cases, an artery was punctured and 5 min of compression prevented additional morbidity.…”
Section: Discussionmentioning
confidence: 54%
“…The most important factors contributing to this complication are the experience of the surgeon and the attention paid to the anatomical landmarks. 10 In our series, only one case (0.42%) developed pneumothorax, which was treated by tube drainage. In four cases, an artery was punctured and 5 min of compression prevented additional morbidity.…”
Section: Discussionmentioning
confidence: 54%
“…This rate of sepsis usually occurs in patients who are monitored long-term with central access compared with the 180-day evaluation period in this study. Other major complications such as venous thrombosis and catheter fracture are much less common, occurring at rates of 2.0% to 2.5% and 0.2%, respectively (7)(8)(9). The present study was not powered to detect significant differences in the aforementioned complications due to their low incidence.…”
Section: Discussionmentioning
confidence: 87%
“…Several studies have documented the relative superiority of TIVADs over non-totally implanted devices [3][4][5][6] . Nevertheless, factors affecting device survival remain a major concern.…”
Section: Discussionmentioning
confidence: 99%
“…The principal advantages of these access ports are; no external dressing, lower infection rates than non-totally implantable devices and allowance of patients to perform normal physical activities. It is common practice to insert totally implantable venous access devices (TIVADs) in cancer patients beginning a course of chemotherapy to eliminate potential peripheral venous access problems [4,5] ; however, risk factors impacting the survival of TIVADs remain unclear. Accordingly, this retrospective cohort study analyzed the risk factors for failure of the TIVADs and compared adverse events among risk factors.…”
Section: Introductionmentioning
confidence: 99%